—

Regeneron Pharmaceuticals Inc (REGN) — Technical state

As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-13)
  • Trend: Regeneron Pharmaceuticals Inc trades 17.1% above its 50-day and 27.9% above its 200-day moving average. (as of 2026-11-13)
  • Index seat: HALO Growth 100

Regeneron discovers, develops, manufactures and sells medicines across eye disease, immune and inflammatory conditions, cardiovascular and metabolic disorders, neurological and infectious disease, rare disease, cancer and blood disorders. Its marketed products include an eye injection for macular degeneration and related retinal conditions, an injection for atopic dermatitis and asthma, a skin-cancer treatment, a cholesterol-lowering injection and a rheumatoid arthritis treatment.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the REGN overview. Research diary readings, not advice.

Trending

Above its 20-, 50- and 200-day — still in an uptrend.

The moving-average stack

FAQ · from the current data · as of 2026-11-13

Quick answers

What is the current Closelooknet signal on REGN?

Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is REGN above its 50-day and 200-day moving averages?

As of 2026-11-13, Regeneron Pharmaceuticals Inc trades +17.1% above its 50-day and +27.9% above its 200-day average, with the 20-day +8.7% away.

How far is REGN from its 52-week high?

3.7% below the 52-week high and 77% above the 52-week low, as of 2026-11-13.

Mentioned on Closelooknet

Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.